Stage in the life cycle of health technologies and obstacles
| Stage of the lifecycle in health technology | Obstacles |
|---|---|
| Research | Inadequate research funding: higher volumes of resources are needed Fragile or non-existent strategies of universities and science and technology institutes for PM |
| Innovation | Regulations Gap in researcher skills to transform research into innovation Inadequate funding for startups: mechanisms in Brazil are not sufficient and adequate for the challenges of PM Open innovation in health care is still incipient. The corporate venture is in its initial phase Large national pharmaceutical companies are shyly structuring themselves to work in PM |
| Initial diffusion | Doctor’s culture Lack of understanding of technologies by patients Existence of few clinical protocols |
| Incorporation | Inadequacy of HTA methods Insufficient epidemiological studies No comparison between technologies |
| Widespread use | Insufficient human resources and skills Inadequate infrastructure High cost of treatments No integrated patient information system |
| Stage of the lifecycle in health technology | Obstacles |
|---|---|
| Research | Inadequate research funding: higher volumes of resources are needed |
| Innovation | Regulations |
| Initial diffusion | Doctor’s culture |
| Incorporation | Inadequacy of HTA methods |
| Widespread use | Insufficient human resources and skills |